Ülke: Birleşik Krallık
Dil: İngilizce
Kaynak: MHRA (Medicines & Healthcare Products Regulatory Agency)
Fluconazole
PLIVA Pharma Ltd
J02AC01
Fluconazole
50mg
Oral capsule
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 05020100
PACKAGE LEAFLET: INFORMATION FOR THE USER FLUCONAZOLE 50MG AND 200MG CAPSULES READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU.. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Fluconazole is and what it is used for 2. What you need to know before you take Fluconazole. 3. How to take Fluconazole. 4. Possible side-effects 5. How to store Fluconazole. 6. Contents of the pack and other information 1. WHAT FLUCONAZOLE IS AND WHAT IT IS USED FOR Fluconazole is one of a group of medicines called “antifungals”. The active substance is fluconazole. _ _ Fluconazole Capsules are used to treat infections caused by fungi and may also be used to stop you from getting candidal infection. The most common cause of fungal infections is a yeast called _Candida._ ADULTS You might be given this medicine by your doctor to treat the following types of fungal infections: Cryptococcal meningitis – a fungal infection in the brain Coccidioidomycosis – a disease of the bronchopulmonary system Infections caused by _Candida_ and found in the blood stream, body organs (e.g. heart, lungs) or urinary tract Mucosal thrush - infection affecting the lining of the mouth, throat and denture sore mouth Genital thrush – infection of the vagina or penis Skin infections - e.g. athlete's foot, ringworm, jock itch, nail infection You might also be given Fluconazole Capsules to: stop cryptococcal meningitis from coming back stop mucosal trush from coming back reduce recurrence of vaginal trush stop you from getting an infection cau Belgenin tamamını okuyun
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Fluconazole 50 mg Capsules 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each capsule contains 50 mg fluconazole. Excipient(s) with known effect Also contains 16.6mg lactose per capsule. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Capsules, hard. Fluconazole 50 mg Capsules are green-white capsules_._ 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Fluconazole is indicated in the following fungal infections (see section 5.1). Fluconazole is indicated in adults for the treatment of: • Cryptococcal meningitis (see section 4.4). • Coccidioidomycosis (see section 4.4). • Invasive candidiasis. • Mucosal candidiasis including oropharyngeal, oesophageal candidiasis, candiduria and chronic mucocutaneous candidiasis. • Chronic oral atrophic candidiasis (denture sore mouth) if dental hygiene or topical treatment are insufficient. • Vaginal candidiasis, acute or recurrent; when local therapy is not appropriate. • _Candidal balanitis_ when local therapy is not appropriate. • Dermatomycosis including _tinea pedis, tinea corporis, tinea cruris, tinea _ _versicolor_ and dermal _candida_ infections when systemic therapy is indicated. • _Tinea unguium_ (_onychomycosis_) when other agents are not considered appropriate. Fluconazole is indicated in adults for the prophylaxis of: • Relapse of cryptococcal meningitis in patients with high risk of recurrence. • Relapse of oropharyngeal or oesophageal candidiasis in patients infected with HIV who are at high risk of experiencing relapse. • To reduce the incidence of recurrent vaginal candidiasis (4 or more episodes a year). • Prophylaxis of candidal infections in patients with prolonged neutropenia (such as patients with haematological malignancies receiving chemotherapy or patients receiving Hematopoietic Stem Cell Transplantation (see section 5.1). Fluconazole is indicated in term newborn infants, infants, toddlers, children, and adolescents aged from 0 to 17 years Belgenin tamamını okuyun